therapy

Article contentNyxoah announces the commercial launch of its innovative treatment Genio® in EnglandThe first patients to have the Genio device implanted At UCLH, LondonArticle contentMont Saint Guibert, Belgium – December 13, 2024, 8:05 AM…

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire…

Written by Dina Beasley LOS ANGELES (Reuters) - Student Zoe Davis, 20, was just weeks into her first year of school when she returned to the hospital with severe sickle cell pain earlier this month. She does what she can to prevent the…

Doctors and nurses rarely learn in school how to tell a family that a loved one will not survive. Yet healthcare workers face the enormous burden of tragedy, illness, and death in a highly stressful environment as a constant routine part…

(Reuters) - Vertex Pharmaceuticals Inc. sued the U.S. Department of Health and Human Services on Monday seeking a court declaration that its fertility support program for patients prescribed its gene-editing treatment Kasgevi does not…

Evening pictures Ionis Pharmaceuticals (Nasdaq: ions(Amazon) announced Friday that its investigational treatment dondalorsen has achieved positive results in two late-stage trials for hereditary angioedema (HAE), a rare genetic disorder…

“Physical therapists are movement experts,” says Roger Hare. American Physical Therapy Association (APTA) Chairman. It's especially important for older adults because of this Half of the physical therapy patients Are over 65 years of…

hapabapa/iStock Editorial via Getty Images Bristol Myers Squibb (NYSE:BMY) announced Saturday that its experimental schizophrenia therapy KarXT, acquired as part of its recent Karuna Therapeutics buyout, indicated a well-tolerated…

(Reuters) -Verve Therapeutics said on Tuesday that it had paused enrollment for an early-stage study testing its experimental gene editing therapy for high cholesterol after a patient experienced a severe drug-related adverse event. Shares…

Israeli phage therapy company BiomX (NYSE: PHGE) has announced a merger with Adaptive Phage Therapeutics (APT). The merged company is also raising $50 million in a private placement. Existing shareholders in BiomX will…